- PRESS RELEASE 2013: Dec, 3 Paris, Louvain Belgium: BMSystems and Aepodia sign a strategic R&D collaboration to decipher the Fibromyalgia & chronic facial pain mechanisms to bring novel therapeutic strategies to patients.
- PRESS RELEASE Oct 28, 2013 Paris: Theranexus, the CEA and BMSystems sign an agreement on new therapeutic strategies for use in psychiatry.
- PRESS RELEASE: BMSystems and Persistent Systems Launch Strategic Joint Systems Biology R&D Initiative.
Bio-Modeling Systems: The Mechanisms-based Medicine Company that delivers.
BMSystems is the first and, to date the only integrative systems biology company that succeeded to create in-silico non-mathematical heuristic models validated in-vivo. These outputs led to discoveries, patents, or operational businesses through its innovative business model, in the fields of infectious diseases, neurology, psychiatry, oncology, dermatology, immunology and innovative bioprocesses for industrial biotech.
The life-modeling issue
We invented CADI*™
CADI™ is the first and, to date, the only solution that succeeded to create in-vivo validated in-silico heuristic models of complex human pathologies & physiological processes.
Since 2004, BMSystems implements its disruptive collaborative research strategy and its innovative business model to generate scientific and business successes.
*CADI™ : Computer Assisted Deductive Integration